Article ; Online: Purinergic Signaling of ATP in COVID-19 Associated Guillain-Barré Syndrome.
2021 Volume 16, Issue 1, Page(s) 48–58
Abstract: ... closely associated with critical cases of infection with "severe acute respiratory syndrome of coronavirus ... neurodegenerative diseases. In this context, Guillain-Barré syndrome, an immune-mediated inflammatory neuropathy, has been ... Declared as a global public health emergency, coronavirus disease 2019 (COVID-19) is presented ...
| Abstract | Declared as a global public health emergency, coronavirus disease 2019 (COVID-19) is presented as a disease of the respiratory tract, although severe cases can affect the entire organism. Several studies have shown neurological symptoms, ranging from dizziness and loss of consciousness to cerebrovascular and neurodegenerative diseases. In this context, Guillain-Barré syndrome, an immune-mediated inflammatory neuropathy, has been closely associated with critical cases of infection with "severe acute respiratory syndrome of coronavirus 2" (SARS-CoV-2), the etiological agent of COVID-19. Its pathophysiology is related to a generalized inflammation that affects the nervous system, but neurotropism was also revealed by the new coronavirus, which may increase the risk of neurological sequel, as well as the mortality of the disease. Thus, considering the comorbidities that SARS-CoV-2 infection can promote, the modulation of purinergic signaling can be applied as a potential therapy. In this perspective, given the role of adenosine triphosphate (ATP) in neural intercommunication, the P2X7 receptor (P2X7R) acts on microglia cells and its inhibition may be able to reduce the inflammatory condition of neurodegenerative diseases. Finally, alternative measures to circumvent the reality of the COVID-19 pandemic need to be considered, given the severity of critical cases and the viral involvement of multiple organs. |
|---|---|
| MeSH term(s) | Adenosine Triphosphate ; COVID-19/complications ; Guillain-Barre Syndrome/etiology ; Guillain-Barre Syndrome/physiopathology ; Humans ; Receptors, Purinergic ; Receptors, Purinergic P2X7 ; Signal Transduction |
| Chemical Substances | Receptors, Purinergic ; Receptors, Purinergic P2X7 ; Adenosine Triphosphate (8L70Q75FXE) |
| Language | English |
| Publishing date | 2021-01-18 |
| Publishing country | United States |
| Document type | Journal Article ; Review |
| ZDB-ID | 2227405-4 |
| ISSN | 1557-1904 ; 1557-1890 |
| ISSN (online) | 1557-1904 |
| ISSN | 1557-1890 |
| DOI | 10.1007/s11481-020-09980-1 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.